Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWEIDD-2749 is an antiviral ribonucleoside analog.1 Incorporation of EIDD-2749 into RSV or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA inhibits viral RNA-dependent RNA polymerase (RdRp) and induces transcriptional stalling in cell-free assays. It reduces viral yield in HEp-2 cells infected with clinical isolates of respiratory syncytial virus (RSV; EC50s = 0.61-1.2 µM). EIDD-2749 reduces apical virus shedding in RSV-infected isolated human airway epithelial (HAE) cells (EC50 = 55 nM). In vivo, EIDD-2749 (5 mg/kg) reduces lung virus load in a mouse model of RSV infection. It also reduces nasal viral titers in a ferret model of SARS-CoV-2 infection when administered at doses of 15 and 50 mg/kg.
WARNING This product is not for human or veterinary use.
1. 4'-